- Home
- CNM vs QGEN Comparison
CNM vs QGEN Comparison
Compare CNM & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNM
- QGEN
- Stock Information
- Founded
- CNM 1996
- QGEN 1986
- Country
- CNM United States
- QGEN Netherlands
- Employees
- CNM N/A
- QGEN N/A
- Industry
- CNM Durable Goods
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNM Consumer Discretionary
- QGEN Health Care
- Exchange
- CNM Nasdaq
- QGEN Nasdaq
- Market Cap
- CNM 9.6B
- QGEN 9.1B
- IPO Year
- CNM 2021
- QGEN 1996
- Fundamental
- Price
- CNM $54.80
- QGEN $45.14
- Analyst Decision
- CNM Buy
- QGEN Buy
- Analyst Count
- CNM 11
- QGEN 8
- Target Price
- CNM $57.91
- QGEN $50.53
- AVG Volume (30 Days)
- CNM 1.9M
- QGEN 1.5M
- Earning Date
- CNM 06-10-2025
- QGEN 05-07-2025
- Dividend Yield
- CNM N/A
- QGEN 2.92%
- EPS Growth
- CNM N/A
- QGEN N/A
- EPS
- CNM 2.13
- QGEN 0.42
- Revenue
- CNM $7,441,000,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- CNM $5.39
- QGEN $6.11
- Revenue Next Year
- CNM $4.42
- QGEN $6.10
- P/E Ratio
- CNM $25.74
- QGEN $107.32
- Revenue Growth
- CNM 11.03
- QGEN 3.31
- 52 Week Low
- CNM $37.22
- QGEN $37.63
- 52 Week High
- CNM $58.29
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- CNM 60.30
- QGEN 66.03
- Support Level
- CNM $53.52
- QGEN $41.77
- Resistance Level
- CNM $55.08
- QGEN $43.01
- Average True Range (ATR)
- CNM 1.25
- QGEN 0.70
- MACD
- CNM 0.07
- QGEN 0.24
- Stochastic Oscillator
- CNM 93.24
- QGEN 93.82
About CNM Core & Main Inc.
Core & Main Inc is a specialty distributor focusing on water, wastewater, storm drainage, and fire protection products and services. Catering to municipalities, private water companies, and contractors, it serves municipal, non-residential, and residential markets nationwide. Its diverse product line includes pipes, valves, fittings, storm drainage products, fire protection products, and meter products. Revenue is principally generated from pipes, valves, and fittings. The company operates across three construction sectors: municipal, non-residential, and residential, contributing to reliable infrastructure development nationwide.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).